Plasmid IL-12 electroporation in melanoma

References

• Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1:841 - 5; PMID: 6329708
   PubMed Web of Science ®Google Scholar
• Bodles-Brakhop AM, Heller R, Draghia-Akli R. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol Ther 2009; 17:585 - 92; http://dx.doi.org/10.1038/mt.2009.5; PMID: 19223870
   PubMed Web of Science ®Google Scholar
• Gilbert R, Jaroszeski MJ, Heller L, Heller R. Electric field enhanced plasmid delivery to liver hepatocellular carcinomas. Technol Cancer Res Treat 2002; 1:355 - 64; PMID: 12625761
   PubMed Web of Science ®Google Scholar
• Titomirov AV, Sukharev S, Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1991; 1088:131 - 4; http://dx.doi.org/10.1016/0167-4781(91)90162-F; PMID: 1703441
   PubMed Web of Science ®Google Scholar
• Hargrave B, Downey H, Strange R Jr., Murray L, Cinnamond C, Lundberg C, et al. Electroporation-mediated gene transfer directly to the swine heart. Gene Ther 2012; http://dx.doi.org/10.1038/gt.2012.15; PMID: 22456328
   PubMed Web of Science ®Google Scholar
• Mir LM, Bureau MF, Rangara R, Schwartz B, Scherman D. Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III 1998; 321:893 - 9; http://dx.doi.org/10.1016/S0764-4469(99)80003-1; PMID: 9879468
   PubMed Web of Science ®Google Scholar
• Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P, et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci U S A 1999; 96:6417 - 22; http://dx.doi.org/10.1073/pnas.96.11.6417; PMID: 10339602
   PubMed Web of Science ®Google Scholar
• Gehl J, Sorensen TH, Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T, et al. In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999; 1428:233 - 40; http://dx.doi.org/10.1016/S0304-4165(99)00094-X; PMID: 10434041
   PubMed Web of Science ®Google Scholar
• De Vry J, Martínez-Martínez P, Losen M, Temel Y, Steckler T, Steinbusch HW, et al. In vivo electroporation of the central nervous system: a non-viral approach for targeted gene delivery. Prog Neurobiol 2010; 92:227 - 44; http://dx.doi.org/10.1016/j.pneurobio.2010.10.001; PMID: 20937354
   PubMed Web of Science ®Google Scholar
• Glass LF, Pepine ML, Fenske NA, Jaroszeski M, Reintgen DS, Heller R. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 1996; 132:1353 - 7; http://dx.doi.org/10.1001/archderm.1996.03890350095015; PMID: 8915314
   PubMed Web of Science ®Google Scholar
• Glass LF, Jaroszeski M, Gilbert R, Reintgen DS, Heller R. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 1997; 37:596 - 9; http://dx.doi.org/10.1016/S0190-9622(97)70178-6; PMID: 9344200
   PubMed Web of Science ®Google Scholar
• Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77:964 - 71; http://dx.doi.org/10.1002/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0; PMID: 8608491
   PubMed Web of Science ®Google Scholar
• Mir LM, Glass LF, Sersa G, Teissié J, Domenge C, Miklavcic D, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77:2336 - 42; http://dx.doi.org/10.1038/bjc.1998.388; PMID: 9649155
   PubMed Web of Science ®Google Scholar
• Byrne CM, Thompson JF. Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors. Expert Rev Anticancer Ther 2006; 6:671 - 8; http://dx.doi.org/10.1586/14737140.6.5.671; PMID: 16759159
   PubMed Web of Science ®Google Scholar
• Reed SD, Li S. Electroporation advances in large animals. Curr Gene Ther 2009; 9:316 - 26; http://dx.doi.org/10.2174/156652309788921062; PMID: 19545229
   PubMed Web of Science ®Google Scholar
• Somiari S, Glasspool-Malone J, Drabick JJ, Gilbert RA, Heller R, Jaroszeski MJ, et al. Theory and in vivo application of electroporative gene delivery. Mol Ther 2000; 2:178 - 87; http://dx.doi.org/10.1006/mthe.2000.0124; PMID: 10985947
   PubMed Web of Science ®Google Scholar
• Heller LC, Ingram SF, Lucas ML, Gilbert RA, Heller R. Effect of electrically mediated intratumor and intramuscular delivery of a plasmid encoding IFN alpha on visible B16 mouse melanomas. Technol Cancer Res Treat 2002; 1:205 - 9; PMID: 12622513
   PubMed Web of Science ®Google Scholar
• Heller L, Jaroszeski MJ, Coppola D, Pottinger C, Gilbert R, Heller R. Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Ther 2000; 7:826 - 9; http://dx.doi.org/10.1038/sj.gt.3301173; PMID: 10845719
   PubMed Web of Science ®Google Scholar
• Durieux A-C, Bonnefoy R, Manissolle C, Freyssenet D. High-efficiency gene electrotransfer into skeletal muscle: description and physiological applicability of a new pulse generator. Biochem Biophys Res Commun 2002; 296:443 - 50; http://dx.doi.org/10.1016/S0006-291X(02)00901-4; PMID: 12163039
   PubMed Web of Science ®Google Scholar
• Khan AS, Smith LC, Abruzzese RV, Cummings KK, Pope MA, Brown PA, et al. Optimization of electroporation parameters for the intramuscular delivery of plasmids in pigs. DNA Cell Biol 2003; 22:807 - 14; http://dx.doi.org/10.1089/104454903322625019; PMID: 14683591
   PubMed Web of Science ®Google Scholar
• Satkauskas S, Bureau MF, Puc M, Mahfoudi A, Scherman D, Miklavcic D, et al. Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther 2002; 5:133 - 40; http://dx.doi.org/10.1006/mthe.2002.0526; PMID: 11829520
   PubMed Web of Science ®Google Scholar
• Heller LC, Heller R. Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther 2010; 10:312 - 7; http://dx.doi.org/10.2174/156652310791823489; PMID: 20557286
   PubMed Web of Science ®Google Scholar
• Lucas ML, Heller L, Coppola D, Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002; 5:668 - 75; http://dx.doi.org/10.1006/mthe.2002.0601; PMID: 12027550
   PubMed Web of Science ®Google Scholar
• Li S, Zhang X, Xia X. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy. J Natl Cancer Inst 2002; 94:762 - 8; http://dx.doi.org/10.1093/jnci/94.10.762; PMID: 12011227
   PubMed Web of Science ®Google Scholar
• Goto T, Nishi T, Kobayashi O, Tamura T, Dev SB, Takeshima H, et al. Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo. Mol Ther 2004; 10:929 - 37; http://dx.doi.org/10.1016/j.ymthe.2004.07.028; PMID: 15509510
   PubMed Web of Science ®Google Scholar
• Lee C-F, Chang S-Y, Hsieh D-S, Yu D-S. Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine. J Urol 2004; 171:1343 - 7; http://dx.doi.org/10.1097/01.ju.0000103924.93206.93; PMID: 14767345
   PubMed Web of Science ®Google Scholar
• Collins CG, Tangney M, Larkin JO, Casey G, Whelan MC, Cashman J, et al. Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors. Cancer Gene Ther 2006; 13:1061 - 71; http://dx.doi.org/10.1038/sj.cgt.7700976; PMID: 16874363
   PubMed Web of Science ®Google Scholar
• Ohe Y, Kasai T, Heike Y, Saijo N. [Clinical trial of IL-12 for cancer patients]. Gan To Kagaku Ryoho 1998; 25:177 - 84; PMID: 9474926
   PubMedGoogle Scholar
• Gollob JA, Mier JW, Veenstra K, McDermott DF, Clancy D, Clancy M, et al. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response. Clin Cancer Res 2000; 6:1678 - 92; PMID: 10815886
   PubMed Web of Science ®Google Scholar
• Lucas ML, Heller R. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma. DNA Cell Biol 2003; 22:755 - 63; http://dx.doi.org/10.1089/104454903322624966; PMID: 14683586
   PubMed Web of Science ®Google Scholar
• Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993; 178:1223 - 30; http://dx.doi.org/10.1084/jem.178.4.1223; PMID: 8104230
   PubMed Web of Science ®Google Scholar
• Brunda MJ, Luistro L, Hendrzak JA, Fountoulakis M, Garotta G, Gately MK. Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12. J Immunother Emphasis Tumor Immunol 1995; 17:71 - 7; http://dx.doi.org/10.1097/00002371-199502000-00001; PMID: 7647958
   PubMed Web of Science ®Google Scholar
• Brunda MJ, Luistro L, Rumennik L, Wright RB, Dvorozniak M, Aglione A, et al. Antitumor activity of interleukin 12 in preclinical models. Cancer Chemother Pharmacol 1996; 38:Suppl S16 - 21; http://dx.doi.org/10.1007/s002800051031; PMID: 8765410
   PubMed Web of Science ®Google Scholar
• Yue FY, Geertsen R, Hemmi S, Burg G, Pavlovic J, Laine E, et al. IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity?. Eur J Immunol 1999; 29:1762 - 73; http://dx.doi.org/10.1002/(SICI)1521-4141(199906)29:06<1762::AID-IMMU1762>3.0.CO;2-F; PMID: 10382738
   PubMed Web of Science ®Google Scholar
• Heller LC, Jaroszeski MJ, Coppola D, Heller R. Comparison of electrically mediated and liposome-complexed plasmid DNA delivery to the skin. Genet Vaccines Ther 2008; 6:16; http://dx.doi.org/10.1186/1479-0556-6-16; PMID: 19055808
   PubMedGoogle Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45:228 - 47; http://dx.doi.org/10.1016/j.ejca.2008.10.026; PMID: 19097774
   PubMed Web of Science ®Google Scholar
• Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26:5896 - 903; PMID: 19029422
   PubMed Web of Science ®Google Scholar
• Cha E, Daud A, McNeel D, Heller R, Fong L. Systemic immune responses induced by intratumoral plasmid IL-12 electroporation in patients with melanoma. ASCO (2011).
   Google Scholar
• Kaufman HL, Kim DW, DeRaffele G, Mitcham J, Coffin RS, Kim-Schulze S. Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma. Ann Surg Oncol 2010; 17:718 - 30; http://dx.doi.org/10.1245/s10434-009-0809-6; PMID: 19915919
   PubMed Web of Science ®Google Scholar
• Kaufman HL, Cohen S, Cheung K, DeRaffele G, Mitcham J, Moroziewicz D, et al. Local delivery of vaccinia virus expressing multiple costimulatory molecules for the treatment of established tumors. Hum Gene Ther 2006; 17:239 - 44; http://dx.doi.org/10.1089/hum.2006.17.239; PMID: 16454657
   PubMed Web of Science ®Google Scholar
• Triozzi PL, Allen KO, Carlisle RR, Craig M, LoBuglio AF, Conry RM. Phase I study of the intratumoral administration of recombinant canarypox viruses expressing B7.1 and interleukin 12 in patients with metastatic melanoma. Clin Cancer Res 2005; 11:4168 - 75; http://dx.doi.org/10.1158/1078-0432.CCR-04-2283; PMID: 15930353
   PubMed Web of Science ®Google Scholar